{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:47:13Z","timestamp":1785797233683,"version":"3.56.0"},"reference-count":30,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Laryngorhinootologie"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:p>Schwitzen im Kopfbereich kann bei Tr\u00e4ger*innen von H\u00f6rger\u00e4ten und teilimplantierbaren H\u00f6rsystemen zu lokalen Hautproblemen wie Juckreiz oder Ekzemen, erh\u00f6htem Energieverbrauch der H\u00f6rhilfen sowie Funktionsst\u00f6rungen f\u00fchren. Ziel dieser Studie war es, H\u00e4ufigkeiten zu erfassen und die Wirksamkeit von Botulinumtoxin-A (BoNT-A) -Injektionen zur Behandlung der lokalen Hyperhidrose zu evaluieren.<\/jats:p>\n                  <jats:p>In einer monozentrischen Beobachtungsstudie wurden 51 Patient*innen mit Cochlea-Implantaten, aktivem Mittelohrimplantat, Knochenleitungs- und konventionellen H\u00f6rger\u00e4ten mittels eines 12-teiligen Anamnesefragebogens zu Schwei\u00dfproduktion, ger\u00e4teassoziierten Problemen sowie Begleitumst\u00e4nden befragt. Bei ausgepr\u00e4gter Hyperhidrose erfolgte eine intrakutane Behandlung mit BoNT-A (n=6).<\/jats:p>\n                  <jats:p>22\/51 Befragten (43%) gaben eine h\u00e4ufige, 17\/51 (33%) eine seltene Schwei\u00dfproduktion im Kopfbereich an. Bei 35\/51 Patient*innen (69%) traten lokale Probleme wie Hautirritationen oder Juckreiz auf. 16\/51 (31%) berichteten \u00fcber einen erh\u00f6hten Energieverbrauch der H\u00f6rger\u00e4te und 16\/51 (31%) gaben eine Beeintr\u00e4chtigung des Tragekomforts oder der Funktion an. Nach intrakutaner BoNT-A-Behandlung berichteten alle behandelten Patient*innen \u00fcber eine deutliche Besserung der Beschwerden, Funktionsausf\u00e4lle wurden nicht mehr beobachtet.<\/jats:p>\n                  <jats:p>Die erhobenen Daten lassen eine nicht unerhebliche Anzahl von Patient*innen mit schwei\u00dfbedingten Problemen erkennen und deuten darauf hin, dass eine verst\u00e4rkte Schwei\u00dfproduktion teilweise mit relevanten Beeintr\u00e4chtigungen assoziiert ist. Diese kann sowohl lokale Hautreizungen als auch technische St\u00f6rungen verursachen. Intrakutane BoNT-A-Injektionen sind eine effektive, sichere und praktikable Therapieoption zur Reduktion Hyperhidrose-bedingter Beschwerden.<\/jats:p>","DOI":"10.1055\/a-2850-4392","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:55:21Z","timestamp":1776984921000},"page":"502-509","source":"Crossref","is-referenced-by-count":0,"title":["Botulinumtoxin reduziert schwei\u00dfbedingte Probleme bei Tr\u00e4ger*innen von H\u00f6rhilfen \u2013 eine klinische Studie"],"prefix":"10.1055","volume":"105","author":[{"given":"David","family":"Oestreicher","sequence":"first","affiliation":[{"name":"Universit\u00e4tsmedizin G\u00f6ttingen, NDS, Germany","place":["G\u00f6ttingen"],"department":["Klinik f\u00fcr Hals-Nasen-Ohrenheilkunde"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Beutner","sequence":"first","affiliation":[{"name":"Universit\u00e4tsmedizin G\u00f6ttingen, NDS, Germany","place":["G\u00f6ttingen"],"department":["Klinik f\u00fcr Hals-Nasen-Ohrenheilkunde"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7206-1357","authenticated-orcid":false,"given":"Shabnam","family":"Shahpasand","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin G\u00f6ttingen, NDS, Germany","place":["G\u00f6ttingen"],"department":["Klinik f\u00fcr Hals-Nasen-Ohrenheilkunde"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Laskawi","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin G\u00f6ttingen, NDS, Germany","place":["G\u00f6ttingen"],"department":["Klinik f\u00fcr Hals-Nasen-Ohrenheilkunde"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Blum","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin G\u00f6ttingen, NDS, Germany","place":["G\u00f6ttingen"],"department":["Klinik f\u00fcr Hals-Nasen-Ohrenheilkunde"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-1046","authenticated-orcid":false,"given":"Nicola","family":"Strenzke","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin G\u00f6ttingen, NDS, Germany","place":["G\u00f6ttingen"],"department":["Klinik f\u00fcr Hals-Nasen-Ohrenheilkunde"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00106-017-0409-x","article-title":"Botulinumtoxin in der HNO-Heilkunde \u2013 ein Update","volume":"65","author":"R Laskawi","year":"2017","journal-title":"HNO"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00106-004-1098-9","article-title":"Botulinum toxin in otorhinolaryngology","volume":"52","author":"S Rohrbach","year":"2004","journal-title":"HNO"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000055761","article-title":"Treatment of gustatory sweating with botulinum toxin: special aspects","volume":"63","author":"R Laskawi","year":"2001","journal-title":"ORL J Oto-Rhino-Laryngol Its Relat Spec"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF00181883","article-title":"Botulinum toxin treatment in patients with hemifacial spasm","volume":"251","author":"R Laskawi","year":"1994","journal-title":"Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol \u2013 Head Neck Surg"},{"key":"ref5","first-page":"644","article-title":"Therapy of Frey syndrome with botulinum toxin A. Experiences with a new method of treatment","volume":"43","author":"C Drobik","year":"1995","journal-title":"HNO"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.amjsurg.2016.01.020","article-title":"Frey\u02bcs syndrome after superficial parotidectomy: role of the sternocleidomastoid muscle flap: a prospective nonrandomized controlled trial","volume":"212","author":"M Grosheva","year":"2016","journal-title":"Am J Surg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1064-7406(03)00075-0","article-title":"Management of Frey\u2019s syndrome and hypersialorrhea with botulinum toxin","volume":"11","author":"O Guntinas-Lichius","year":"2003","journal-title":"Facial Plast Surg Clin N Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007368","article-title":"SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea","volume":"92","author":"WH Jost","year":"2019","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/a-1677-4008","article-title":"Therapy of Hemifacial Spasm with Botulinum Toxin: an Update","volume":"90","author":"WH Jost","year":"2022","journal-title":"Fortschr Neurol Psychiatr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0194-5998(99)70268-8","article-title":"Botulinum Toxin Injection to Improve Tracheoesophageal Speech after Total Laryngectomy","volume":"120","author":"MM Zormeier","year":"1999","journal-title":"Otolaryngol Neck Surg"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10072-011-0560-1","article-title":"Botulinum toxin type A: an effective treatment to restore phonation in laryngectomized patients unable to voice","volume":"32","author":"L Bartolomei","year":"2011","journal-title":"Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/2473974X19834553","article-title":"Inability to Belch and Associated Symptoms Due to Retrograde Cricopharyngeus Dysfunction: Diagnosis and Treatment","volume":"3","author":"RW Bastian","year":"2019","journal-title":"OTO Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/2473974X20917644","article-title":"Partial Cricopharyngeal Myotomy for Treatment of Retrograde Cricopharyngeal Dysfunction","volume":"4","author":"RW Bastian","year":"2020","journal-title":"OTO Open"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00056-023-00498-8","article-title":"Comparison of the efficacy of occlusal splint and botulinum toxin therapies in patients with temporomandibular disorders with sleep bruxism","volume":"85","author":"H Hosgor","year":"2024","journal-title":"J Orofac Orthop Fortschritte Kieferorthop\u00e4die"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00106-012-2530-1","article-title":"Regulierung der periaurikul\u00e4ren Schwei\u00dfproduktion durch Botulinumtoxin A zur Sicherung von Funktion und Tragekomfort von H\u00f6rger\u00e4ten, Mittelohr- und Cochleaimplantaten","volume":"60","author":"R Laskawi","year":"2012","journal-title":"HNO"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/toxins17040163","article-title":"Botulinum Toxin in the Treatment of Hair and Scalp Disorders: Current Evidence and Clinical Applications","volume":"17","author":"SM Perez","year":"2025","journal-title":"Toxins"},{"issue":"S 4","key":"ref17","first-page":"36","article-title":"Botulinum toxin in the treatment of focal hyperhidrosis","volume":"113","author":"P Schnider","year":"2001","journal-title":"Wien Klin Wochenschr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00105-012-2333-z","article-title":"Botulinumtoxin bei fokaler Hyperhidrose: Ein aktueller \u00dcberblick","volume":"63","author":"C Hosp","year":"2012","journal-title":"Hautarzt"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/jdv.12278","article-title":"Botulinum toxin B in the treatment of craniofacial hyperhidrosis","volume":"28","author":"M Karlqvist","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.toxicon.2012.11.011","article-title":"Botulinum neurotoxins: Mechanism of action","volume":"67","author":"AP Tighe","year":"2013","journal-title":"Toxicon"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1080\/09638280701568296","article-title":"Pharmacology of therapeutic botulinum toxin preparations","volume":"29","author":"D Dressler","year":"2007","journal-title":"Disabil Rehabil"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM200102153440704","article-title":"Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)","volume":"344","author":"M Heckmann","year":"2001","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/ced.13310","article-title":"Postmenopausal craniofacial hyperhidrosis","volume":"43","author":"K Eustace","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/1346-8138.15029","article-title":"Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B","volume":"46","author":"P Cabreus","year":"2019","journal-title":"J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68401","article-title":"Botulinum Toxin for the Treatment of Postmenopausal Craniofacial Hyperhidrosis","author":"B Patrick","year":"2024","journal-title":"Cureus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211004213","article-title":"Effect of botulinum toxin in stellate ganglion for craniofacial hyperhidrosis: a case report","volume":"49","author":"JH Park","year":"2021","journal-title":"J Int Med Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"Doc08","DOI":"10.3205\/CTO000147","article-title":"Hearing aids: indications, technology, adaptation, and quality control","volume":"16","author":"U Hoppe","year":"2017","journal-title":"GMS Curr Top Otorhinolaryngol \u2013 Head Neck Surg"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1684\/ejd.2007.0322","article-title":"Craniofacial hyperhidrosis successfully treated with botulinum toxin type A","volume":"18","author":"D Anders","year":"2008","journal-title":"Eur J Dermatol EJD"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1046\/j.1365-2133.2000.03839.x","article-title":"Effective treatment of frontal hyperhidrosis with botulinum toxin A","volume":"143","author":"I Kinkelin","year":"2000","journal-title":"Br J Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/archderm.139.6.731","article-title":"Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study","volume":"139","author":"M Naumann","year":"2003","journal-title":"Arch Dermatol"}],"container-title":["Laryngo-Rhino-Otologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2850-4392.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:33:24Z","timestamp":1785796404000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2850-4392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":30,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2026,8,3]]},"published-print":{"date-parts":[[2026,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2850-4392","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0935-8943","1438-8685"],"issn-type":[{"value":"0935-8943","type":"print"},{"value":"1438-8685","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}